Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$1.65.

  • Medifast's EPS (Basic) fell 245714.29% to -$1.65 in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.7, marking a year-over-year decrease of 104444.44%. This contributed to the annual value of -$1.7 for FY2025, which is 99473.68% down from last year.
  • As of Q4 2025, Medifast's EPS (Basic) stood at -$1.65, which was down 245714.29% from -$0.21 recorded in Q3 2025.
  • Over the past 5 years, Medifast's EPS (Basic) peaked at $4.0 during Q2 2021, and registered a low of -$1.65 during Q4 2025.
  • Over the past 5 years, Medifast's median EPS (Basic) value was $2.29 (recorded in 2022), while the average stood at $1.72.
  • Within the past 5 years, the most significant YoY rise in Medifast's EPS (Basic) was 13066.67% (2025), while the steepest drop was 245714.29% (2025).
  • Over the past 5 years, Medifast's EPS (Basic) (Quarter) stood at $2.94 in 2021, then decreased by 16.67% to $2.45 in 2022, then plummeted by 77.55% to $0.55 in 2023, then plummeted by 87.27% to $0.07 in 2024, then tumbled by 2457.14% to -$1.65 in 2025.
  • Its last three reported values are -$1.65 in Q4 2025, -$0.21 for Q3 2025, and $0.23 during Q2 2025.